Alpha-Ketoglutaric Acid

Alpha-Ketoglutaric Acid

SCHEMBL1471943

NC(CC(=O)O)C(=O)O.O=C(O)CCC(=O)C(=O)O

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC6A2SLC6A3

The experimentally established mechanism targets of Alpha-Ketoglutaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 1/20 0.58
▸ SLC13A3 Q8WWT9 1/20 0.58
▸ EGLN1 Q9GZT9 1/20 0.58
▸ OR51E2 Q9H255 1/20 0.58
▸ GRIK1 P39086 11/20 0.50
▸ GRIK2 Q13002 5/20 0.50
▸ GRIA4 P48058 5/20 0.50
▸ GRIK3 Q13003 5/20 0.50
▸ GRIK5 Q16478 5/20 0.50
▸ GRIA2 P42262 4/20 0.50
▸ GRIA1 P42261 3/20 0.50
▸ GRM1 Q13255 2/20 0.50
▸ GRM2 Q14416 2/20 0.50
▸ GRM8 O00222 2/20 0.50
▸ GRM6 O15303 2/20 0.50
▸ GRM7 Q14831 2/20 0.50
▸ GRM4 Q14833 2/20 0.50
▸ GRIN2D O15399 1/20 0.50
▸ GRIN3B O60391 1/20 0.50
▸ GSR P00390 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Alpha-Ketoglutaric Acid SCHEMBL4366423 1.00 MAPK1 (0.58) MAPK1SLC13A3EGLN1OR51E2GRIK1
Aspartic Acid SCHEMBL27820838 0.89 GRIK1 (0.56) EGLN1GRIK1GRIK2GRIA4GRIK3
Aspartic Acid SCHEMBL28284774 0.89 GRIK1 (0.61) EGLN1GRIK1GRIK2GRIA4GRIK3
Alpha-Ketoglutaric Acid SCHEMBL5276805 0.88 MAPK1 (0.54) MAPK1SLC13A3EGLN1OR51E2GRIK1
Aspartic Acid SCHEMBL12076452 0.87 GRIK1 (0.58) EGLN1GRIK1GRIK2GRIA4GRIK3
Glutamic Acid SCHEMBL5148593 0.87 GRM8 (0.56) MAPK1SLC13A3EGLN1OR51E2GRIK1
Glutamic Acid SCHEMBL148727 0.83 GRM8 (0.75) MAPK1SLC13A3EGLN1OR51E2GRIK1
D-Glutamate SCHEMBL148726 0.83 GRM8 (0.75) MAPK1SLC13A3EGLN1OR51E2GRIK1
Alpha-Ketoglutaric Acid SCHEMBL1471949 0.83 EGLN1 (0.58) MAPK1SLC13A3EGLN1OR51E2GRIK1
D-Glutamate SCHEMBL6138602 0.83 GRM8 (0.75) MAPK1SLC13A3EGLN1OR51E2GRIK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190091300-A1 METHODS OF TREATING CANCER OF THE CENTRAL NERVOUS SYSTEM YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2019-03-28 — — US disclosed
US-10159717-B2 Methods of treating cancer of the central nervous system YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2018-12-25 — — US disclosed
CN-106868066-A The method for producing the microorganism of O acetylhomoserines and O acetylhomoserines being produced using the microorganism CJ第制糖株式会社 2017-06-20 — — CN disclosed
CN-103797027-B Variant polypeptide having homoserine acetyltransferase activity and microorganism expressing same CJ 第制糖株式会社 2017-05-17 — — CN disclosed
CN-104911136-A Microorganism producing O-acetyl-homoserine and the method of producing O-acetyl-homoserine using the microorganism CJ CHEILJEDANG CORP 2015-09-16 — — CN disclosed
US-20150216949-A1 METHODS OF TREATING CANCER OF THE CENTRAL NERVOUS SYSTEM YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2015-08-06 — — US disclosed
US-9034319-B2 Methods of treating cancer of the central nervous system YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2015-05-19 — — US disclosed
US-20110070218-A1 METHODS OF TREATING CANCER OF THE CENTRAL NERVOUS SYSTEM YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2011-03-24 — — US disclosed
US-7767204-B2 Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2010-08-03 — — US disclosed
US-20090304661-A1 Method And Composition For Proctecting Neuronal Tissue From Damage Induced By Elevated Glutamate Levels YEDA RESEARCH AND DEVELOPMENT CO. LTD. AT THE WEIZMANN INSTITUTE OF SCEINCE (IL) 2009-12-10 — — US disclosed
US-20090186358-A1 Pathway Analysis of Cell Culture Phenotypes and Uses Thereof WYETH (US) 2009-07-23 — — US disclosed
US-20080233096-A1 transaminase, dehydrogenase, decarboxylase, ligase as glutamate modifying enzymes and oxaloacetate, pyruvate, NAD+, NADP+, 2-oxohexanedioic acid, 2-oxo-3-sulfopropionate, 2-oxo-3-sulfinopropionic acid, 2-oxo-3-phenylpropionic acid co-factors to enhance brain to blood efflux YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2008-09-25 — — US disclosed
US-20080233099-A1 Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2008-09-25 — — US disclosed
US-7404951-B2 Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2008-07-29 — — US disclosed
US-20060024284-A1 Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2006-02-02 — — US disclosed
US-20050005324-A1 Gene promoters isolated from potato and use thereof DAI ZIYU (US) 2005-01-06 — — US disclosed
US-20020170095-A1 Gene promoters isolated from potato and use thereof BATTELLE MEMORIAL INSTITUTE 2002-11-14 — — US disclosed
EP-1172439-A1 THERMOSTABLE ENZYME HAVING AMINOTRANSFERASE ACTIVITY AND GENE ENCODING THE SAME National Institute of Advanced Industrial Science and Technology (JP) 2002-01-16 — — EP disclosed
CN-1179792-A Reagent stabilized by coenzyme reduction system TRACE SCIENT LTD (AU) 1998-04-22 — — CN disclosed
US-4235962-A REAGENTS COMPRISING ASPARATE, ALANINE, 2-OXOGLUTARATE AND REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE THE DOW CHEMICAL COMPANY (US) 1980-11-25 — — US disclosed
Send feedback